Clinical trials for Ovarian / Fallopian tubes / Peritoneum cancer

128 currently recruiting clinical trials
Phase 3 Ovarian / Fallopian tubes / Peritoneum cancer #NCT06824467 #2023-508015-23-00
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Stage III Stage IV 1 2 Recurrence 6 months or more after platinum treatme... Chemotherapy Chemotherapy
Systemic Treatment-Naive Systemic Treatment-Naive
Centre François Baclesse (Caen ), Centre Oscar Lambret (Lille), Hôpital Cochin (Paris ), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital Privé des Côtes d'Armor (Plérin) (and 5 more...)
Merck Sharp & Dohme LLC
Phase 3 Ovarian / Fallopian tubes / Peritoneum cancer #NCT06819007
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Serous high grade carcinoma (HGSOC) Endometrioid carcinoma Clear cell carcinoma Mucinous carcinoma Other epithelial ovarian cancer Stage III Stage IV Locally Advanced Metastatic HER2 None Chemotherapy Targeted therapy
BRCA 1/2
Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), CHU Saint-Étienne (Saint-Priest-en-Jarez), Centre Eugene Marquis (Rennes), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Léon Bérard (Lyon) (and 5 more...)
Daiichi Sankyo
Phase 3 Ovarian / Fallopian tubes / Peritoneum cancer #NCT06072781
Epithelial ovarian cancer Serous low grade carcinoma (LGSOC) Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Léon Bérard (Lyon), Centre Oscar Lambret (Lille), Institut Curie - Paris (Paris), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Verastem
Phase 3 Ovarian / Fallopian tubes / Peritoneum cancer #NCT05445778 #2022-501606-35-01
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Serous high grade carcinoma (HGSOC) Greater than or equal to 75% 1 Recurrence 6 months or more after platinum treatme... Chemotherapy Chemotherapy
Systemic Treatment-Naive Systemic Treatment-Naive
Centre hospitalier universitaire François Mitterrand (Dijon)
Abbvie
Phase 2 / Phase 3 Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT03651206 #2024-516782-36-00
Other ovarian cancer Carcinosarcoma Other Localized Locally Advanced Metastatic None 1 2 3 or more Chemotherapy Chemotherapy
Immunotherapy Targeted therapy Immunotherapy Targeted therapy
Centre Eugene Marquis (Rennes), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut Curie - Paris (Paris), Groupe Hospitalier Diaconesses - Site Croix Saint Simon (Paris) (and 8 more...)
Groupe ARCAGY/GINÉCO
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT06581432 #2023-510429-14-00
HER2 Positive Locally Advanced Metastatic Metastatic Castration-resistant HER2 1 2 3 or more
Systemic Treatment-Naive
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif)
Boehringer Ingelheim
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST #NCT06760819 #2024-517419-62-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Ampullary carcinoma Gastrointestinal stromal tumor Squamous cell carcinoma Other HER2 Positive Locally Advanced Metastatic Metastatic Castration-resistant HER2 1
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Oscar Lambret (Lille), Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 1 more...)
Bayer
Phase 2 Ovarian / Fallopian tubes / Peritoneum cancer #NCT05489211 #2022-000776-19
Cancer de l’ovaire (sous-étude 4)
Locally Advanced Metastatic 1 2 3 or more
Antibody Drug Conjugates (ADC) Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon)
AstraZeneca
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT03767075 #2024-514238-19-00
Module 2 bras 2B, Module 3 bras 3A et 3C
Locally Advanced Metastatic Metastatic Castration-resistant EGFR FGFR MET 1 2 3 or more
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Institut d'oncologie du Vall d'Hebron
Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer #NCT03175224 #2024-514542-37-00
Locally Advanced Metastatic MET 1 2 3 or more
BRAF EGFR KRAS G12C KRAS non G12C NTRK-1/2/3 RET ALK ROS-1 Systemic Treatment-Naive Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Hôpital de la Timone AP-HM (Marseille), Centre Léon Bérard (Lyon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Hôpital Bichat - Claude Bernard - AP-HP (Paris)
Apollomics